ORGO Organogenesis Holdings Inc.

8-K Current Report

Filed: February 26, 2026

Health Care

Pharmaceutical Preparations

Organogenesis Holdings Inc. (ORGO) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year fiscal 2025 earnings released Feb 26, 2026 — see Exhibit 99.1 for actual financial figures
• Press release furnished (not filed), limiting legal liability under Exchange Act Section 18

Other Organogenesis Holdings Inc. 8-K Filings

8-K Feb 23, 2026

Get deeper insights on Organogenesis Holdings Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.